Patrick J. Heron
Director, Trubion Pharmaceuticals, Inc.
Companies
- MBX Biosciences, Inc.Board member Sep 12, 2024 to now1
- HilleVax, Inc.Board member Apr 28, 2022 to now2
- Arcutis Biotherapeutics, Inc.Board member Jan 30, 2020 to now3
- Mirum PharmaceuticalsBoard member Jul 17, 2019 to now4
- Imago BioSciences, Inc.Board member Jul 15, 2021 to Jul 20, 20215
- Vaxcyte, Inc.Board member Jun 11, 2020 to Jun 3, 20216
- Frazier Lifesciences Acquisition CorpBoard member Dec 8, 2020 to Dec 17, 20207
- Iterum Therapeutics plcBoard member May 24, 2018 to Jul 6, 20208
- Passage BIO, Inc.Board member Feb 27, 2020 to Mar 3, 20209
- COLLEGIUM PHARMACEUTICAL, INCBoard member May 6, 2015 to Sep 14, 201510
- Cidara TherapeuticsBoard member Apr 14, 2015 to Apr 22, 201511
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mirum Pharmaceuticals MIRM3,572,615 shares12$294.3M at $82.39Jan 27, 2026
- MBX Biosciences, Inc. MBX4,552,774 shares13$230.9M at $50.71Sep 16, 2024
- Arcutis Biotherapeutics, Inc. ARQT59,661 shares14$1.7M at $28.82Jun 12, 2026
- HilleVax, Inc.8,552,536 shares15Jun 25, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2026Granted 5,778 shares of Arcutis Biotherapeutics, Inc.16
- Jan 23, 2026Bought 131,425 shares at $68.48 of Mirum Pharmaceuticals12
- Jan 23, 2026Other 159,277 shares of Mirum Pharmaceuticals12
- Jun 23, 2025Granted 17,199 shares of HilleVax, Inc.15
- Jun 13, 2025Bought 2,646 shares at $13.08 of Arcutis Biotherapeutics, Inc.17
- Jun 12, 2025Granted 7,609 shares of Arcutis Biotherapeutics, Inc.18
- Jun 5, 2025Bought 378 shares at $13.41 of Arcutis Biotherapeutics, Inc.19
- Jun 4, 2025Bought 1,890 shares at $13.32 of Arcutis Biotherapeutics, Inc.19
- May 29, 2025Exercised options 5,703 shares of Mirum Pharmaceuticals20
- May 22, 2025Bought 2,520 shares at $13.65 of Arcutis Biotherapeutics, Inc.21
- May 21, 2025Bought 2,520 shares at $13.66 of Arcutis Biotherapeutics, Inc.21
- May 15, 2025Bought 2,520 shares at $13.62 of Arcutis Biotherapeutics, Inc.22
- May 14, 2025Bought 6,300 shares at $13.76 of Arcutis Biotherapeutics, Inc.23
- May 13, 2025Bought 2,374 shares at $13.76 of Arcutis Biotherapeutics, Inc.23
- May 9, 2025Bought 6,300 shares at $13.60 of Arcutis Biotherapeutics, Inc.24
- Mar 17, 2025Bought 21 shares at $43.93 of Mirum Pharmaceuticals25
- Mar 14, 2025Bought 528 shares at $44.11 of Mirum Pharmaceuticals25
- Mar 11, 2025Bought 963 shares at $43.77 of Mirum Pharmaceuticals26
- Mar 10, 2025Bought 577 shares at $43.37 of Mirum Pharmaceuticals26
- Mar 10, 2025Bought 758 shares at $42.66 of Mirum Pharmaceuticals26
- Mar 7, 2025Bought 580 shares at $43.21 of Mirum Pharmaceuticals27
- Mar 6, 2025Bought 1,335 shares at $43.89 of Mirum Pharmaceuticals27
- Mar 5, 2025Bought 267 shares at $44.55 of Mirum Pharmaceuticals28
- Mar 4, 2025Bought 56 shares at $45.96 of Mirum Pharmaceuticals28
- Mar 4, 2025Bought 1,279 shares at $45.55 of Mirum Pharmaceuticals28
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMBX Biosciences, Inc., Board member
- 2SEC EDGARHilleVax, Inc., Board member
- 3
- 4SEC EDGARMirum Pharmaceuticals, Board member
- 5
- 6SEC EDGARVaxcyte, Inc., Board member
- 7
- 8
- 9SEC EDGARPassage BIO, Inc., Board member
- 10
- 11SEC EDGARCidara Therapeutics, Board member
- 12
- 13
- 14
- 15
- 16SEC EDGARForm 4 filed Jun 9, 2026
- 17SEC EDGARForm 4 filed Jun 17, 2025
- 18SEC EDGARForm 4 filed Jun 16, 2025
- 19SEC EDGARForm 4 filed Jun 6, 2025
- 20SEC EDGARForm 4 filed Jun 2, 2025
- 21SEC EDGARForm 4 filed May 23, 2025
- 22SEC EDGARForm 4 filed May 19, 2025
- 23SEC EDGARForm 4 filed May 15, 2025
- 24SEC EDGARForm 4 filed May 13, 2025
- 25SEC EDGARForm 4 filed Mar 18, 2025
- 26SEC EDGARForm 4 filed Mar 12, 2025
- 27SEC EDGARForm 4 filed Mar 10, 2025
- 28SEC EDGARForm 4 filed Mar 6, 2025